brand-logo

Welcoming our new Business Planning and Analysis Manager

Welcoming our new Business Planning and Analysis Manager

 

Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis.

 

Known for his ability to turn complex financial data into actionable insights that drive business growth and efficiency, David’s extensive expertise in financial systems and modelling makes him a perfect fit for Accelagen.

Since joining Accelagen mid-way through 2023, David has already made significant contributions to our rapid growth and has been instrumental in enhancing our world-leading work. His role focuses on developing and implementing financial management and forecasting strategies, streamlining processes for maximum efficiency. David also leads in delivering profitability reporting, financial modelling, and senior leadership team reporting, bringing a new level of precision to our financial management.

 

David’s passion for the health sector is evident, and he is dedicated to providing the data necessary for informed decision-making and amplifying Accelagen’s impact in the industry.

 

Outside work, David is a health and fitness enthusiast, enjoying morning jogs and bike rides. His love for travel and exploring new cultures reflects his openness to new experiences.

Accelagen is thrilled to have David on board. With the ideal blend of professional expertise and personal commitment, we look forward to his continued impact in shaping the future of Accelagen.

You might also like...​

You might also like...​

Welcoming our new Business Planning and Analysis Manager

Welcoming our new Business Planning and Analysis Manager   Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis. […]

Read More
New Appointment Post: Welcoming Cassandra Vung

Accelagen Staff Announcement – Welcoming Cassandra Vung We are thrilled to introduce a recent addition to our Accelagen team, Cassandra Vung. With a strong track record in clinical research, Cassandra joined the team in late April 2023 and has already become an invaluable part of our work, positively impacting the future of human health and […]

Read More
Accelagen Staff Announcement – Sahar Bassal

Accelagen Staff Announcement – Sahar Bassal   One thing that we never lose sight of at Accelagen is that, on the end of every product, every trial, every protocol, every drug — is a patient. And it is our responsibility, and our privilege, to help our innovative global clients to translate ground-breaking science into meaningful […]

Read More